Search arXivSearch

arXiv · 2402.17244

The status and challenges for prostate SBRT treatments in United States proton therapy centers: An NRG Oncology practice survey

Abstract

A survey was designed to inquire about the practice of proton SBRT treatment for prostate cancer. The survey was distributed to all 30 proton therapy centers in the United States that participate in the National Clinical Trial Network in Feb. 2023. The survey focused on usage, patient selection criteria, prescriptions, target contours, dose constraints, treatment plan optimization and evaluation methods, patient-specific QA, and IGRT methods. Results: We received responses from 25 centers (83% participation). Only 8 respondent proton centers (32%) reported performing SBRT of the prostate. The remaining 17 centers cited three primary reasons for not offering this treatment: no clinical need, lack of volumetric imaging, and/or lack of clinical evidence. Only 1 center cited the reduction in overall reimbursement as a concern for not offering prostate SBRT. Several common practices among the 8 centers offering SBRT for the prostate were noted, such as using Hydrogel spacers, fiducial markers, and MRI for target delineation. Most proton centers (87.5%) utilized pencil beam scanning (PBS) delivery and completed Imaging and Radiation Oncology Core (IROC) phantom credentialing. Treatment planning typically used parallel opposed lateral beams, and consistent parameters for setup and range uncertainties were used for plan optimization and robustness evaluation. Measurements-based patient-specific QA, beam delivery every other day, fiducial contours for IGRT, and total doses of 35-40 GyRBE were consistent across all centers. However, there was no consensus on the risk levels for patient selection. Conclusion: Prostate SBRT is used in about 1/3 of proton centers in the US. There was a significant consistency in practices among proton centers treating with proton SBRT. It is possible that the adoption of proton SBRT may become more common if proton SBRT is more commonly offered in clinical trials.

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Jiajian Shen, Paige A. Taylor, Carlos E. Vargas, Minglei Kang, Jatinder Saini, Jun Zhou, Peilong Wang, Wei Liu, Charles B. Simone II, Ying Xiao, Liyong Lin. 2024-02-27. The status and challenges for prostate SBRT treatments in United States proton therapy centers: An NRG Oncology practice survey. https://doi.org/10.1016/j.ijpt.2024.100020

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related papers

A digital-twin framework for forecasting treatment-day imaging with contour uncertainty in adaptive proton radiotherapy

Head-and-neck anatomy changes over a six-to-seven-week proton course, and the anatomy of a later week cannot be imaged when the plan is made. We present a digital-twin framework that forecasts a patient's treatment-day anatomy as an ensemble of predicted CTs with propagated contours and quantifies the uncertainty of the forecast contours. The twin is a library of previously treated patients with planning and weekly quality-assurance CTs (QACTs), made patient-specific by a two-step foundation-model deformable registration: a cross-patient field carries each library patient onto the current patient, and a longitudinal field, estimated in the current patient's frame, carries that patient's planning-to-QACT change onto the current patient's own planning CT. A library of 302 observations from 88 patients yields about 300 replicates per patient, each a deformation that occurred in a treated patient. The dispersion of the propagated contours, resolved by outward normal, is six-direction contour uncertainty in millimeters. This is uncertainty in the input to the forecast, which library patient the current patient follows, rather than in model parameters, and it is unchanged when the registration engine is exchanged. On ten patients with clinician contours on two QACTs, the library alone fixes the anisotropic shape of the uncertainty (4.5 to 6.2 mm); the first QACT narrows it by a factor of 3.2 to 3.6 without a contour being drawn; an approved contour improves the center but not the width. The estimate orders directions correctly but is not Gaussian-calibrated. A clinical target volume expansion is worked out as one application.

physics.med-ph

On phase aberration estimation using common mid-angle speckle correlations

Phase aberrations, despite degrading ultrasound images, also encode valuable information about the spatial distribution of the speed of sound in tissue. In pulse-echo ultrasound, we can quantify them by exploiting speckle correlations. Among existing strategies, correlations between steered acquisitions that share a common mid-angle have proven particularly effective for inferring the speed of sound. Their phases can be linearly related to the phase aberrations undergone by both the incident and reflected wavefronts. This relationship has so far been demonstrated only through geometric arguments based on point reflectors. Here, we develop a rigorous theoretical formalism that extends this relationship to the speckle regime, completing the previously established linear model and clarifying its underlying assumptions. More importantly, we build on this formalism to analyze correlation-phase fluctuations arising from aberration-induced speckle decorrelation. The analysis reveals that phase variance is governed by the relative loss of coherence, which increases approximately linearly with the square of the correlation phases. Local correlation-phase estimates therefore become increasingly uncertain as their magnitude grows. Experimental measurements in a uniform tissue-mimicking phantom show excellent agreement with the predicted variance. Beyond providing a theoretical basis for advancing speed-of-sound imaging, this formalism establishes the accuracy limit of common-mid-angle correlation phases, offering a benchmark for evaluating more advanced aberration-estimation techniques.

physics.med-ph

Buccal-Lingual Analysis and Inflammation Tracking in Oral Soft Tissues Using Quantitative Ultrasound: A Preclinical Study

Four out of 10 adults aged 30 years or older in the USA are impacted by periodontal diseases which span a spectrum of inflammatory conditions. Currently, a subjective, invasive and a semi-quantitative approach, termed bleeding on probing, is employed in clinics for inflammation assessment. The long-term goal of this study is to fill the current clinical diagnostic gap in dentistry by proposing quantitative ultrasound (QUS)-based biomarkers for inflammation diagnosis and monitoring. Here, as one of the early works in this area, we investigated two QUS parameters for characterizing periodontal inflammation in gingival tissues using a longitudinal preclinical porcine study: attenuation coefficient slope (ACS) and backscatter intensity (BSI). Our study included eight pigs imaged intraorally (24 MHz) at four bi-weekly timepoints from week 0 (healthy) to week 6 (post inflammation inoculation) at their interproximal sites of the third premolars (PM3-Mes) from all quadrants. Moreover, we compared gingival tissues surrounding a tooth at lingual/palatal side versus buccal side at the second molar (M2-Dis) in healthy condition. Our results showed that gingival ACS at all inflammation timepoints were significantly lower than healthy gingival ACS (1.69 \pm 0.53 dB/cm.MHz) using a mixed effect analysis (week 6: 1.08 \pm 0.25 dB/cm.MHz). Longitudinal comparison of BSI did not demonstrate any statistical significance. Gingival ACS and BSI at lingual/palatal versus buccal sides of M2-Dis did not exhibit any statistical significance. These ACSs were linearly correlated with R-squared = 0.89 and a correlation slope of 0.87. For BSI, Bland-Altman analysis demonstrated no difference in mean BSI, although variability was high. These findings highlight the promising potential of ultrasonography paired with QUS to complement current standard of care in dentistry.

physics.med-ph